Stereotaxis (STXS) Interest Expenses (2010 - 2026)
Stereotaxis (STXS) posted quarterly Interest Expenses of $6.8 million for Q1 2026, up 2211.9% year-over-year from $294000.0 in Q1 2025, and up 416.88% quarter-over-quarter from $1.3 million in Q4 2025.
Stereotaxis (STXS) Interest Expenses (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Interest Expenses for 17 consecutive years, with $6.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 2211.9% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 270.21% YoY), while the FY2025 annual figure was $2.2 million, down 94.34% from the prior year.
- Interest Expenses grew to $6.8 million in Q1 2026 per STXS's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $6.8 million in Q1 2026 and bottomed at $220000.0 in Q2 2022.
- Historically, Interest Expenses has averaged $853823.5 across 5 years, with a median of $259000.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest Expenses sank 62.82% — and 2026, when it jumped 2211.9%.
- Stereotaxis' Interest Expenses stood at $240000.0 in 2022, then rose by 7.92% to $259000.0 in 2023, then surged by 287.26% to $1.0 million in 2024, then surged by 31.11% to $1.3 million in 2025, then jumped by 416.88% to $6.8 million in 2026.
- Business Quant data shows STXS's Interest Expenses at $6.8 million in Q1 2026, $1.3 million in Q4 2025, and $298000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.60 Mn |
| Jun 30, 2026 | 6.60 Mn |
| Mar 31, 2026 | 6.80 Mn |
| Mar 31, 2026 | 6.80 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 298,000.00 |
| Sep 30, 2025 | 298,000.00 |
| Jun 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | 1.88 Mn |
| Mar 31, 2025 | 294,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Mar 31, 2024 | 258,000.00 |
| Mar 31, 2024 | 258,000.00 |